Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Niacin. Always confirm against the full prescribing information.
100 interactions
Abacavir
Niacin may increase the hepatotoxic activities of Abacavir.
Level 2 evidence
Abiraterone
Niacin may increase the hepatotoxic activities of Abiraterone.
Level 2 evidence
Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Niacin.
Level 2 evidence
Acebutolol
The metabolism of Acebutolol can be decreased when combined with Niacin.
Level 2 evidence
Acetaminophen
The metabolism of Acetaminophen can be decreased when combined with Niacin.
Level 2 evidence
Acetazolamide
Niacin may increase the hepatotoxic activities of Acetazolamide.
Level 2 evidence
Acitretin
Acitretin may increase the hepatotoxic activities of Niacin.
Level 2 evidence
Albendazole
The metabolism of Albendazole can be decreased when combined with Niacin.
Level 2 evidence
Alendronic acid
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Alendronic acid.
Level 2 evidence
Allantoin
The therapeutic efficacy of Allantoin can be increased when used in combination with Niacin.
Level 2 evidence
Allopurinol
Allopurinol may increase the hepatotoxic activities of Niacin.
Level 2 evidence
Almotriptan
The metabolism of Almotriptan can be decreased when combined with Niacin.
Level 2 evidence
Enter your NPI to unlock 18 major interactions for Niacin
Niacin has 690 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Niacin has 97 major, 379 moderate, and 214 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Niacin. Always confirm against the full prescribing information.